CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 6.73M |
| Revenue (ttm) | 25.00K |
| Net Income (ttm) | -1.52M |
| Shares Out | 51.74M |
| EPS (ttm) | -0.03 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,264 |
| Average Volume | 173,387 |
| Open | 12.12 |
| Previous Close | 13.00 |
| Day's Range | 12.00 - 14.00 |
| 52-Week Range | 8.00 - 29.40 |
| Beta | 0.60 |
| RSI | 64.45 |
| Earnings Date | May 27, 2026 |
About CRISM Therapeutics
CRISM Therapeutics Corporation develops a drug delivery technology for the clinical performance of cancer treatments for solid tumors through the local delivery of chemotherapy drugs. Its lead product is ChemoSeed, an implantable biodegradable drug delivery technology for the delivery of chemotherapy directly into cancer tissues. The company also offers formulation and consultancy services. The company was formerly known as Amur Minerals Corporation and changed its name to CRISM Therapeutics Corporation in May 2024. CRISM Therapeutics Corporati... [Read more]
Financial Performance
In 2024, CRISM Therapeutics's revenue was 25,000, a decrease of -44.44% compared to the previous year's 45,000. Losses were -607,000, 209.7% more than in 2023.
Financial StatementsNews
AIM Market Roundup: Renalytix, Sunrise Resources, Crism Therapeutics
Renalytix, Sunrise Resources, Crism Therapeutics are today's top risers, while Distil, ECR Minerals take the biggest fall on London's AIM
AIM Market Roundup: Mobile Tornado, Mediazest, Pri0r1ty Intelligence
Mobile Tornado, MediaZest, Pri0r1ty Intelligence are today's top risers, while Crism Therapeutics, Versarien take the biggest fall on AIM
AIM Market Roundup: Surface Transforms, AFC Energy, Empyrean Energy
Surface Transforms, AFC Energy, Empyrean are today's top risers, while Argentex, Crism Therapeutics take the biggest fall on London's AIM